Max Healthcare Institute Limited (BOM:543220)

Market Cap	1.21T
Revenue (ttm)	70.28B
Net Income (ttm)	10.76B
Shares Out	972.15M
EPS (ttm)	11.01
PE Ratio	113.26
Forward PE	65.66
Dividend	1.50 (0.12%)
Ex-Dividend Date	Jul 4, 2025

Volume	8,591
Average Volume	52,851
Open	1,236.05
Previous Close	1,243.80
Day's Range	1,236.05 - 1,257.90
52-Week Range	837.00 - 1,314.30
Beta	0.29
RSI	50.11
Earnings Date	Aug 6, 2025

About Chimerix

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness service...

• Industry: General Medical and Surgical Hospitals
• Founded: 2001
• Employees: 15,114
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543220

Financial Performance

In 2024, Max Healthcare Institute's revenue was 70.28 billion, an increase of 30.01% compared to the previous year's 54.06 billion. Earnings were 10.76 billion, an increase of 1.72%.